Dr. Bert Vanmierlo
ActiveDr. Bert Vanmierlo has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €352k and a net result of €331k. Equity is shrinking by ~2.7% per year across the filed fiscal years. Its solvency ranks better than 33% of 16424 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
81
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency67▲+39
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 2.88 against 0.7 in 2024; short-term debt: 13% and cash: 0.7% of total assets), but 58% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
42%
Return on assets
39.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €352k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
60 d late
2023
30 d late
2022
61 d late
2021
9 d early
2020
10 d late
2019
8 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€352k▲ 1,524%
2024 · €22k
2018: €186k
2019: €25k
2020: €25k
2021: €30k
2022: €24k
2023: €22k
2024: €22k
2018 → 2025
Total assets
€839k=
2024 · €838k
2018: €292k
2019: €499k
2020: €275k
2021: €264k
2022: €342k
2023: €762k
2024: €838k
2018 → 2025
Net result
€331k▲ 25.1%
2024 · €264k
2018: €94k
2019: €123k
2020: €120k
2021: €145k
2022: €184k
2023: €192k
2024: €264k
2018 → 2025
Working capital
€205k
2024 · €-119k
2018: €161k
2019: €-12k
2020: €-7k
2021: €-3k
2022: €-64k
2023: €-101k
2024: €-119k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€30k-€24k▼ 19.1%€22k▼ 7.8%€22k▼ 2.5%€352k▲ 1,524%
Operating result€187k-€242k▲ 29.4%€269k▲ 11.0%€359k▲ 33.6%€433k▲ 20.7%
Net result€145k-€184k▲ 27.1%€192k▲ 4.2%€264k▲ 37.6%€331k▲ 25.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 21% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €839k
Fixed assets
€525k▼ 5.2%
Current assets
€314k▲ 10.3%
Equity and liabilities €839k
Equity
€352k▲ 1,524%
Debt
€486k▼ 40.5%
The debt ratio falls from 97.4% to 58.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€453k▲
2024 · €389k
Cash flow
€351k▲
2024 · €294k
Solvency
42.0%▲
2024 · 2.6%
Current ratio
2.88▲
2024 · 0.70
Quick ratio
2.88▲
2024 · 0.70
Debt / equity
1.38▼
2024 · 37.62
ROE
93.8%
ROA
39.4%▲
2024 · 31.5%
Interest coverage
29.63▲
2024 · 22.91
Debt
€486k▼
2024 · €817k
Debt ≤ 1 year
€109k▼
2024 · €404k
Debt > 1 year
€377k▼
2024 · €413k
Income taxes
€107k▲
2024 · €90k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€838k€839k=
Fixed assets21/28€554k€525k▼
Tangible fixed assets22/27€554k€525k▼
Land and buildings22€488k€501k▲
Plant, machinery and equipment23€11k€3k▼
Furniture and vehicles24€39k€10k▼
Other tangible fixed assets26€16k€11k▼
Current assets29/58€284k€314k▲
Amounts receivable within one year40/41€234k€285k▲
Trade receivables40-€1k
Other amounts receivable41€234k€284k▲
Cash at bank and in hand54/58€49k€6k▼
Deferred charges and accrued income490/1€2k€22k▲
Equity and liabilities
Total equity and liabilities10/49€838k€839k=
Equity10/15€22k€352k▲
Contributions10/11€19k€19k=
Reserves13€2k€334k▲
Distributable reserves133€2k€334k▲
Profit (loss) carried forward14€1k-
Amounts payable17/49€817k€486k▼
Amounts payable after more than one year17€413k€377k▼
Financial debts170/4€413k€377k▼
Amounts payable within one year42/48€404k€109k▼
Current portion of amounts payable after more than one year42€35k€36k▲
Financial debts43€35k-
Credit institutions430/8€35k-
Trade debts44€3k€10k▲
Suppliers440/4€3k€10k▲
Taxes, remuneration and social security45€66k€63k▼
Taxes450/3€66k€63k▼
Other amounts payable47/48€265k-
Accrued charges and deferred income492/3€126-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€30k€20k▼
Other operating charges640/8€3k€2k▼
Non-recurring operating charges66A-€8k
Gross operating margin9900€392k€464k▲
Operating profit (loss)9901€359k€433k▲
Financial income75/76B€12k€19k▲
Recurring financial income75€12k€17k▲
Non-recurring financial income76B-€3k
Financial charges65/66B€17k€15k▼
Recurring financial charges65€17k€15k▼
Profit (loss) for the period before taxes9903€354k€437k▲
Income taxes67/77€90k€107k▲
Profit (loss) for the period9904€264k€331k▲
Profit (loss) for the period to be appropriated9905€264k€331k▲
Appropriation of the result
Profit (loss) to be appropriated9906€266k€332k▲
Profit (loss) brought forward from the previous period14P€2k€1k▼
Transfer to equity691/2-€332k
To other reserves6921-€332k
Profit to be distributed694/7€265k-
Return on contributions (dividend)694€265k-
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Highest result since 2018net €331k ▲25.1%
Operating result €433k, net result €331k, both a record.
31-12
Financial
Liquidity quadruplescurrent ratio 2.88
Current ratio from 0.70 to 2.88; short-term debt falls from €404k to €109k.
31-12
Financial
Equity above €200kEq €352k ▲1524%
8 profitable years in a row build equity to €352k.
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
30-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 61 days late
2022
22-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
10-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 10 days late
2020
23-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
13-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 13 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
24-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Gerard Davidstraat 598000 BruggeGround area
400 m²
Building footprint
100 m²
Volume, LiDAR
747 m³
Parcel 31808M0473/00K003, Flanders · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Bert Vanmierlo, plastisch chirurg
since 20132.223.872.676
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31808M0473/00K003 | Flanders | 400 m² | 1 · 100 m² | 11.2 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Oogcentrum ZIE
BE 0763.381.981
Tongeren-Borgloon · Eq €352k
Dokter PETER BOMANS
BE 0867.088.839
Mechelen · Eq €353k
DR. DAPHNE ARNOLD
BE 0566.958.763
Schilde · Eq €353k
PneumoPlus
BE 0837.804.341
Waregem · Eq €353k
Dr Sabine MOSTINCKX
BE 0889.840.782
Faimes · Eq €353k
Of 16,621 companies in sector 86220 we hold annual accounts for 7,972. 6,620 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-09-2013
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86109Human health activities
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.